We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon
Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
When CLS takes over the operation of the Lucent plants, clearly it's the only remedy for profit. Those plants need positive cash flow in order to implement real growth in that sector. Celestica will meet and surpass this requirement. A $10 billion dollar US deal is something worth investing in. CLS could have made the mistake of buying these plants earlier when they were over valued.
Long positions will be fairly compensated. Can't say much about shorters however...
I expect my arguments to be judged on their merits. That has been the claim from the beginning. If you choose to continue this infantile behaviour, that is certainly your perogative and I have no objections but others on this board might.
I continue to hold Celestica at a profit and I think their business model will by highly lucrative in the future. My opinion of EMS providers is that they are the bullet makers in the tech wars who will survive no matter who wins. Those with enough mass around the world will most efficiently be able to allocate resources as large companies will award them the most contracts because of their geographical coverage and ability to use economic advantage most effectively.
Celestica looks to rebound from tough year By EBN Jan 9, 2002 (9:56 AM)
....Marvin MaGee, president and chief operating officer, says the Toronto-based company will reach $20 billion in revenues in 2004. Prior to announcing the deal with NEC, he spoke with EBN senior editor Claire Serant about the company's customer relationships and outlook...